Zepbound is the preferred weight loss medicine vs. Wegovy and has consistently beaten the latter in U.S. weekly prescriptions ...

Rite Aid pointed to continued financial challenges, exacerbated by "rapidly evolving retail and healthcare landscapes," as ...

Following the sell-off, Lilly trades at a forward price-to-earnings (P/E) of 37 times 2025 analyst estimates, with a price-to ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Vertex has recorded some 25,000 prescriptions for Journavx since its January approval and is in the process of getting big ...

Rite Aid files Chapter 11 again, reflecting deep struggles in the pharmacy industry amid closures, falling margins, and ...